I would have thought this approach applies to cohort 1 and cohort 2 (and is in fact the exact reason for the two cohorts), but not the patients within each cohort. Otherwise there is effectively six cohorts rather than two. To me it would make most sense to dose all patients in cohort 1 as quickly as possible and evaluate how they respond as a group before making the decision regarding cohort 2.
Perhaps Dr. T can clarify that.
- Forums
- ASX - By Stock
- RAC
- Pillar 3 - AML
Pillar 3 - AML, page-110
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.65 |
Change
-0.040(2.37%) |
Mkt cap ! $284.6M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.65 | $119.1K | 71.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7995 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7995 | 1.650 |
1 | 40000 | 1.640 |
4 | 10743 | 1.635 |
3 | 12098 | 1.630 |
2 | 4461 | 1.625 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 400 | 1 |
1.680 | 35 | 1 |
1.685 | 3005 | 1 |
1.690 | 3071 | 3 |
1.720 | 1160 | 1 |
Last trade - 13.25pm 03/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |